PureTech Health (GB:PRTC) has released an update.
PureTech Health PLC has announced its total voting rights and share capital update, revealing its issued share capital as of October 31, 2024, includes 257,927,489 Ordinary Shares with 18,506,177 held in treasury. The company, known for developing innovative biotherapeutics, has a robust pipeline with multiple therapeutics in various stages of clinical development, enhancing its appeal in the financial markets.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
